BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1358 related articles for article (PubMed ID: 19251170)

  • 1. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
    Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
    Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
    Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 2005; 17(4):320-5. PubMed ID: 16428038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
    Luna RA; Gilbert E; Hunter JG
    Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer.
    Hudson M; Lin CL; Habr F
    Hosp Pract (1995); 2011 Feb; 39(1):170-80. PubMed ID: 21441773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O; Ell C
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future developments in total Barrett's eradication: the surgeon's view.
    Watson TJ; Peters JH
    Endoscopy; 2008 Dec; 40(12):1048-51. PubMed ID: 19065490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.